These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 29442287)
1. Recent Developments in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia. Orellana-Noia VM; Douvas MG Curr Hematol Malig Rep; 2018 Apr; 13(2):100-108. PubMed ID: 29442287 [TBL] [Abstract][Full Text] [Related]
2. [Treatment strategy for acute lymphoblastic leukemia in adolescent and young adults]. Yamazaki E Rinsho Ketsueki; 2022; 63(7):826-832. PubMed ID: 35922954 [TBL] [Abstract][Full Text] [Related]
3. [Acute lymphoblastic leukemia in adolescents and young adults]. Hayakawa F Rinsho Ketsueki; 2015 Oct; 56(10):2032-8. PubMed ID: 26458442 [TBL] [Abstract][Full Text] [Related]
4. How I treat acute lymphoblastic leukemia in older adolescents and young adults. Curran E; Stock W Blood; 2015 Jun; 125(24):3702-10. PubMed ID: 25805810 [TBL] [Abstract][Full Text] [Related]
5. Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Across Oncology Services and Regardless of Clinical Trial Enrollment. Wolfson JA; Richman JS; Sun CL; Landier W; Leung K; Smith EP; O'Donnell M; Bhatia S Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1133-1141. PubMed ID: 30262597 [No Abstract] [Full Text] [Related]
6. Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: systematic review and meta-analysis. Ram R; Wolach O; Vidal L; Gafter-Gvili A; Shpilberg O; Raanani P Am J Hematol; 2012 May; 87(5):472-8. PubMed ID: 22388572 [TBL] [Abstract][Full Text] [Related]
7. Acute lymphoblastic leukemia in adolescents and young adults. Rytting ME; Jabbour EJ; O'Brien SM; Kantarjian HM Cancer; 2017 Jul; 123(13):2398-2403. PubMed ID: 28328172 [TBL] [Abstract][Full Text] [Related]
8. Acute lymphoblastic leukemia in adolescents and young adults. Ribera JM; Oriol A Hematol Oncol Clin North Am; 2009 Oct; 23(5):1033-42, vi. PubMed ID: 19825451 [TBL] [Abstract][Full Text] [Related]
9. Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults. McNeer JL; Bleyer A Pediatr Blood Cancer; 2018 Jun; 65(6):e26989. PubMed ID: 29418064 [TBL] [Abstract][Full Text] [Related]
10. Closing the gap: Novel therapies in treating acute lymphoblastic leukemia in adolescents and young adults. Friend BD; Schiller GJ Blood Rev; 2018 Mar; 32(2):122-129. PubMed ID: 28969872 [TBL] [Abstract][Full Text] [Related]
11. [Acute lymphoblastic leukemia in adolescents and young adults: from the viewpoint of pediatricians]. Koh K Rinsho Ketsueki; 2017; 58(8):1024-1030. PubMed ID: 28883265 [TBL] [Abstract][Full Text] [Related]
12. The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study. Gupta S; Pole JD; Baxter NN; Sutradhar R; Lau C; Nagamuthu C; Nathan PC Cancer Med; 2019 May; 8(5):2095-2103. PubMed ID: 30912628 [TBL] [Abstract][Full Text] [Related]
13. The treatment of adolescents and young adults with acute lymphoblastic leukemia. Advani AS; Hanna R Leuk Lymphoma; 2020 Jan; 61(1):18-26. PubMed ID: 31452423 [TBL] [Abstract][Full Text] [Related]
14. Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study. Muffly L; Lichtensztajn D; Shiraz P; Abrahão R; McNeer J; Stock W; Keegan T; Gomez SL Cancer; 2017 Jan; 123(1):122-130. PubMed ID: 27622953 [TBL] [Abstract][Full Text] [Related]
15. Better survivals in adolescent and Young adults, compared to adults with acute lymphoblastic leukemia - A multicenter prospective registry in Thai population. Limvorapitak W; Owattanapanich W; Utchariyaprasit E; Niparuck P; Puavilai T; Tantiworawit A; Rattanathammethee T; Saengboon S; Sriswasdi C; Julamanee J; Saelue P; Polprasert C; Wudhikarn K; Wanitpongpun C; Prayongratana K; Leuk Res; 2019 Dec; 87():106235. PubMed ID: 31675661 [TBL] [Abstract][Full Text] [Related]
16. New developments in ALL in AYA. Boissel N Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):190-196. PubMed ID: 36485092 [TBL] [Abstract][Full Text] [Related]
17. Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults. Guzauskas GF; Villa KF; Vanhove GF; Fisher VL; Veenstra DL J Adolesc Young Adult Oncol; 2017 Mar; 6(1):53-61. PubMed ID: 27779442 [TBL] [Abstract][Full Text] [Related]
18. How should we treat the AYA patient with newly diagnosed ALL? Boissel N Best Pract Res Clin Haematol; 2017 Sep; 30(3):175-183. PubMed ID: 29050690 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A; J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China. Ding Z; Han MZ; Chen SL; Ma QL; Wei JL; Pang AM; Zhang XY; Liang C; Yao JF; Cao YG; Feng SZ; Jiang EL Chin Med J (Engl); 2015 Aug; 128(15):2065-71. PubMed ID: 26228220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]